DexCom (DXCM) Tops Q2 EPS by 11c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $89.35 +1.61%
Revenue Growth %: +9.9%
Financial Fact:
Selling, general and administrative: 75.7M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +9.9%
Financial Fact:
Selling, general and administrative: 75.7M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q2 EPS of $0.34, $0.11 better than the analyst estimate of $0.23. Revenue for the quarter came in at $871.3 million versus the consensus estimate of $841.18 million.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- B.Riley Assumes Anika Therapeutics (ANIK) at Buy
- Arrive AI and DXC Technology partner to bring delivery tech to factories
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
